LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 244

Search options

  1. Book ; Conference proceedings: Jahrestagung 2016 Österreichische Gesellschaft für Rheumatologie und Rehabilitation

    Dejaco, Christian

    1. bis 3. Dezember 2016, Tech Gate Vienna

    (Wiener medizinische Wochenschrift. Skriptum ; Band 13, Heft 10 (2016))

    2016  

    Event/congress Österreichische Gesellschaft für Rheumatologie und Rehabilitation (2016, Wien, Jahrestagung)
    Author's details wissenschaftliche Leitung: Assoz. Prof. Priv.-Doz. Dr. Christian Dejaco
    Series title Wiener medizinische Wochenschrift. Skriptum ; Band 13, Heft 10 (2016)
    Wiener medizinische Wochenschrift
    Collection Wiener medizinische Wochenschrift
    Language German
    Size 22 Seiten, Diagramme
    Publisher Springer-Verlag
    Publishing place Wien
    Publishing country Austria
    Document type Book ; Conference proceedings
    HBZ-ID HT019181880
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  2. Book ; Conference proceedings: Jahrestagung der Österreichischen Gesellschaft für Rheumatologie & Rehabilitation

    Dejaco, Christian

    26. bis 28. November 2015, Tech Gate Vienna

    (Wiener medizinische Wochenschrift. Skriptum ; Band 12/Heft 11 (2015))

    2015  

    Event/congress Österreichische Gesellschaft für Rheumatologie und Rehabilitation (2015, Wien, Jahrestagung)
    Author's details wissenschftliche Leitung: Priv.-Doz. Dr. Christian Dejaco
    Series title Wiener medizinische Wochenschrift. Skriptum ; Band 12/Heft 11 (2015)
    Wiener medizinische Wochenschrift
    Collection Wiener medizinische Wochenschrift
    Language German
    Size 24 Seiten, Illustrationen
    Publisher Springer-Verlag
    Publishing place Wien
    Publishing country Austria
    Document type Book ; Conference proceedings
    HBZ-ID HT018848199
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  3. Article ; Online: Polymyalgia rheumatica: crafting the future of a simple (but not easy!) clinical syndrome.

    Bond, Milena / Dejaco, Christian

    Annals of the rheumatic diseases

    2024  Volume 83, Issue 3, Page(s) 271–273

    MeSH term(s) Humans ; Polymyalgia Rheumatica/diagnosis ; Polymyalgia Rheumatica/drug therapy ; Giant Cell Arteritis ; Syndrome
    Language English
    Publishing date 2024-02-15
    Publishing country England
    Document type Editorial
    ZDB-ID 7090-7
    ISSN 1468-2060 ; 0003-4967
    ISSN (online) 1468-2060
    ISSN 0003-4967
    DOI 10.1136/ard-2023-225192
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Book ; Online ; E-Book: Polymyalgia rheumatica and giant cell arteritis

    DasGupta, Bhaskar / Dejaco, Christian

    (Oxford rheumatology library)

    2016  

    Author's details edited by Bhaskar Dasgupta, Christian Dejaco
    Series title Oxford rheumatology library
    Keywords Polymyalgia Rheumatica / diagnosis ; Polymyalgia Rheumatica / therapy ; Giant Cell Arteritis / diagnosis ; Giant Cell Arteritis / therapy ; Treatment Outcome
    Language English
    Size 1 Online-Ressource (xiv, 154 Seiten), Illustrationen
    Edition First edition
    Publisher Oxford University Press
    Publishing place Oxford
    Publishing country Great Britain
    Document type Book ; Online ; E-Book
    Remark Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    HBZ-ID HT019083066
    ISBN 978-0-19-104543-1 ; 9780198729204 ; 0-19-104543-8 ; 0198729200
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  5. Article ; Online: New blood biomarkers and imaging for disease stratification and monitoring of giant cell arteritis.

    Tomelleri, Alessandro / Dejaco, Christian

    RMD open

    2024  Volume 10, Issue 1

    Abstract: Relapses and late complications remain a concern in giant cell arteritis (GCA). Monitoring strategies are required to effectively tailor treatment and improve patients' outcomes. Current monitoring of GCA is based on clinical assessment and evaluation of ...

    Abstract Relapses and late complications remain a concern in giant cell arteritis (GCA). Monitoring strategies are required to effectively tailor treatment and improve patients' outcomes. Current monitoring of GCA is based on clinical assessment and evaluation of traditional inflammatory markers such as C reactive protein and erythrocyte sedimentation rate; however, this approach has limited value in patients receiving interleukin (IL)-6 blocking agents. New blood biomarkers that are less dependent on the IL-6 axis such as IL-23, B cell activating factor, osteopontin and calprotectin have been explored, but none of them has yet accumulated sufficient evidence to qualify as a routine follow-up parameter. Imaging techniques, including ultrasound and 18F-fluorodeoxyglucose positron emission tomography/computed tomography, potentially offer additional insights; however, the choice of the imaging method as well as its interpretation must be investigated further. Future studies are required to investigate the outcome of patients with GCA whose treatment decisions are based on traditional plus novel (laboratory and imaging) biomarkers as compared with those undergoing conventional monitoring strategies.
    MeSH term(s) Humans ; Giant Cell Arteritis/diagnostic imaging ; Giant Cell Arteritis/complications ; Diagnostic Imaging ; Positron Emission Tomography Computed Tomography ; Glucocorticoids/therapeutic use ; Biomarkers ; Interleukin-6
    Chemical Substances Glucocorticoids ; Biomarkers ; Interleukin-6
    Language English
    Publishing date 2024-02-23
    Publishing country England
    Document type Journal Article
    ZDB-ID 2812592-7
    ISSN 2056-5933 ; 2056-5933
    ISSN (online) 2056-5933
    ISSN 2056-5933
    DOI 10.1136/rmdopen-2023-003397
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Editorial: Ultrasound in rheumatology-A polyhedric imaging tool.

    Di Matteo, Andrea / Dejaco, Christian

    Frontiers in medicine

    2023  Volume 10, Page(s) 1150111

    Language English
    Publishing date 2023-02-07
    Publishing country Switzerland
    Document type Editorial
    ZDB-ID 2775999-4
    ISSN 2296-858X
    ISSN 2296-858X
    DOI 10.3389/fmed.2023.1150111
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Methoden zur Erfassung der Krankheitsaktivität der Polymyalgia rheumatica.

    Reisch, Myriam / Dejaco, Christian

    Zeitschrift fur Rheumatologie

    2023  Volume 82, Issue 5, Page(s) 368–379

    Abstract: Polymyalgia rheumatica (PMR) is the second most frequent inflammatory rheumatic disease in old age. Remission and recurrence are frequently used as endpoints in clinical trials; however, there is as yet no international consensus on the definition of ... ...

    Title translation Methods for assessment of disease activity of polymyalgia rheumatica.
    Abstract Polymyalgia rheumatica (PMR) is the second most frequent inflammatory rheumatic disease in old age. Remission and recurrence are frequently used as endpoints in clinical trials; however, there is as yet no international consensus on the definition of these states, which limits the comparability of published studies. The PMR activity score (PMR-AS) is the only composite score specifically developed for PMR, which together with remission is used to define low, middle and high disease activity. In recent studies the PMR-AS was often used and low disease activity was established as endpoint. The most important limitation of the PMR-AS is the potential influence of the individual variables by comorbidities. The value of C‑reactive protein (CRP) and the erythrocyte sedimentation rate (ESR) are of restricted value in studies using drugs that influence the interleukin 6 (IL-6) axis. In these cases, calprotectin and osteopontin are promising alternative biomarkers, as they have already been shown to reflect disease activity independently of CRP in rheumatoid arthritis. Furthermore, imaging modalities including sonography, magnetic resonance imaging and fluorodeoxyglucose (FDG) positron emission tomography could also be helpful in monitoring disease activity; however, these techniques must first be validated in further studies. The PMR impact scale (PMR-IS) is a composite score to assess the impact of PMR on the patients; however, it has not yet been used in clinical studies. The development of additional patient reported outcomes (PRO) for PMR and the definition of standardized criteria for documentation of remission and recurrence are important questions in the future research agenda for PMR.
    MeSH term(s) Humans ; Polymyalgia Rheumatica/diagnosis ; Polymyalgia Rheumatica/drug therapy ; Giant Cell Arteritis ; Biomarkers ; Blood Sedimentation ; C-Reactive Protein/analysis
    Chemical Substances Biomarkers ; C-Reactive Protein (9007-41-4)
    Language German
    Publishing date 2023-05-15
    Publishing country Germany
    Document type English Abstract ; Journal Article ; Review
    ZDB-ID 124985-x
    ISSN 1435-1250 ; 0340-1855 ; 0301-6382
    ISSN (online) 1435-1250
    ISSN 0340-1855 ; 0301-6382
    DOI 10.1007/s00393-023-01358-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Editorial

    Andrea Di Matteo / Christian Dejaco

    Frontiers in Medicine, Vol

    Ultrasound in rheumatology—A polyhedric imaging tool

    2023  Volume 10

    Keywords ultrasound ; rheumatology ; joint ; soft tissues ; imaging ; Medicine (General) ; R5-920
    Language English
    Publishing date 2023-02-01T00:00:00Z
    Publisher Frontiers Media S.A.
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: New Classification Criteria for Small-Vessel Vasculitis: Is Antineutrophil Cytoplasmic Antibody Inclusion Their Major Advance?

    Dejaco, Christian / Guillevin, Loïc

    Arthritis & rheumatology (Hoboken, N.J.)

    2022  Volume 74, Issue 3, Page(s) 383–385

    MeSH term(s) Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis ; Antibodies, Antineutrophil Cytoplasmic ; Humans
    Chemical Substances Antibodies, Antineutrophil Cytoplasmic
    Language English
    Publishing date 2022-02-02
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 2756371-6
    ISSN 2326-5205 ; 2326-5191
    ISSN (online) 2326-5205
    ISSN 2326-5191
    DOI 10.1002/art.41984
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Controversies in rheumatology: telemedicine-friend or foe?

    Dejaco, Christian / Landewé, Robert B M

    Rheumatology (Oxford, England)

    2022  Volume 62, Issue 8, Page(s) 2661–2664

    Abstract: Telemedicine is increasingly used in rheumatology. While telemedicine guaranteed care of patients during the COVID-19 pandemic, it is now increasingly used to facilitate triage of patients, monitoring of disease activity, and patients' education. In ... ...

    Abstract Telemedicine is increasingly used in rheumatology. While telemedicine guaranteed care of patients during the COVID-19 pandemic, it is now increasingly used to facilitate triage of patients, monitoring of disease activity, and patients' education. In addition, tele-visits as well as remote physio- and psychotherapy are replacing traditional face-to-face contacts between patients and their healthcare provider. While this may save resources in a world in which the gap between the demand and the provision of healthcare increases, there is also a danger of losing essential information, for example by non-verbal communication, that can only be retrieved during face-to-face contact in the office. In addition, it may be challenging to build a trusting relationship between patients and healthcare professionals by virtual means only. Globally acting companies that see market opportunities already amply offer 'simple' technical solutions for telemedicine. While such solutions may seem (economically) interesting at first glance, there is a risk of monopolization, leaving the most valuable parts of healthcare to a small number of profit-seeking companies. In this article, the opportunities and threats of telemedicine in rheumatology are debated. A possible way forward is to complement traditional face-to-face visits with information gained by telemedicine, in order to render these consultations more efficient rather than replacing personal contact by technology.
    MeSH term(s) Humans ; COVID-19/epidemiology ; Rheumatology ; Pandemics ; Telemedicine ; Delivery of Health Care
    Language English
    Publishing date 2022-12-19
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1464822-2
    ISSN 1462-0332 ; 1462-0324
    ISSN (online) 1462-0332
    ISSN 1462-0324
    DOI 10.1093/rheumatology/keac708
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top